Want to join the conversation?
Bill Carcache of Nomura asks about some color on the trajectory of investment spending progressing through 2016. $MA CFO Martina Hund-Mejean said the company doesn't give a quarterly outlook. One has to think about the high single digit as reported numbers for OpeEx in total. That does include all of $MA's opex including FX losses booked in 1Q16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?